JUN 22, 2017 10:30 AM PDT

WEBINAR: Laboratory and Clinical Benefits of Rapid Blood Culture Diagnostics

SPONSORED BY: OpGen
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Director of Clinical Operations, Microbiology Service, Associate Attending Microbiologist, Departments of Medicine and Laboratory Medicine, Memorial Sloan Kettering Cancer Center
    Biography
      Dr. Esther Babady, Ph.D., D (ABMM), is the Director of Clinical Operations for the Microbiology Laboratory Service, Director of the CPEP Clinical Microbiology Fellowship program and an associate attending in the Department of Laboratory Medicine at Memorial Sloan-Kettering Cancer. She received her PhD in Biochemistry and Molecular Biology and completed a post-doctoral CPEP fellowship in Clinical Microbiology both at the Mayo Clinic in Rochester, MN. She is board certified by the American Board of Medical Microbiology (ABMM). Her research interest focuses on the development and applications of rapid, molecular diagnostics tests for detection and analysis of pathogens, particularly in immunocompromised hosts. She has published extensively on the subject including peer-reviewed manuscripts and book chapters.

    Abstract:

    Unfortunately due to technical issues this webinar has been delayed until June 22nd. If you are unable to make the new time, it will be available on demand for you to view.

    DATE: June 22, 2017
    TIME: 10:30am PT, 1:30pm ET

    Sepsis is a major cause of morbidity and mortality in hospitalized patients. Diagnosis of sepsis is challenging and early recognition is a key component in improving outcomes. Blood culture remains the gold standard for diagnosis of sepsis but identification of bacterial or fungal pathogens using conventional methods is often delayed resulting in institution of empiric antimicrobial therapy. Clinical microbiology laboratories now have a few options for rapid identification of pathogens from positive blood cultures. These methods differ in their complexity, turn-around time to results, number of pathogens identified and costs.  This webinar will review current options for rapid pathogen identification from positive blood cultures and discuss the presenter’s experience with the use of AdvanDx QuickFISH BC kits and their impact on the laboratory workflow and patient outcomes.  

    Learning Objectives:

    • Discuss sepsis and the laboratory methods available for rapid diagnosis. 
    • Describe the benefits of rapid blood cultures diagnostics on laboratory workflow and clinical outcomes.

    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    JUL 31, 2019 09:00 AM PDT
    C.E. CREDITS
    JUL 31, 2019 09:00 AM PDT
    DATE: July 31, 2019TIME: 9:00am PT, 12:00pm ET The choroid plexus, which makes up the blood-cerebrospinal fluid barrier in the central nervous system (CNS), lines the ventricle...
    AUG 15, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 15, 2019 09:00 AM PDT
    DATE: August 15, 2019TIME: 9:00am PDT, 12:00pm EDT Radiation therapy is a critical tool for the treatment of brain tumors, however, exposure to high doses of ionizing radiation...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    Loading Comments...
    Show Resources